Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
260 studies found for:    Lymphoma AND (women OR woman OR female)
Show Display Options
Rank Status Study
1 Unknown  Gonadal Toxicity in Women With Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Intervention:
2 Recruiting Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Conditions: Breast Cancer;   Lymphoma;   Hodgkin's Lymphoma
Interventions: Behavioral: surveys;   Other: Blood draw;   Device: Transvaginal ultrasounds
3 Unknown  Detection of Cardiac Fibrosis in Patients With Lymphoma
Condition: Lymphoma
Intervention: Procedure: Cardiac Magnetic Resonance Scan
4 Completed Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma
Condition: Hodgkins Lymphoma
Interventions: Drug: 8 cycles BEACOPPesc plus oral contraceptive;   Drug: 8 cycles BEACOPPesc plus Goserelin
5 Completed Amifostine for Head and Neck Irradiation in Lymphoma
Conditions: Lymphoma;   Hodgkin's Disease;   Non-Hodgkin's Lymphoma
Interventions: Drug: Amifostine;   Radiation: Radiation Therapy
6 Recruiting Lymphoma Bridge Transplant Study
Conditions: Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma
Interventions: Drug: Bendamustine;   Drug: Carmustine;   Drug: Etoposide;   Drug: Melphalan;   Drug: Cytarabine;   Drug: Alemtuzumab;   Biological: Autologous Stem Cell Transplantation;   Biological: Allogeneic Stem Cell Transplantation;   Drug: Rituximab
7 Completed Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
Condition: Lymphoma
Interventions: Biological: pegfilgrastim;   Biological: rituximab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate;   Other: pharmacological study;   Radiation: radiation therapy
8 Recruiting A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer
Condition: Non-Hodgkin's Lymphoma, Solid Cancers
Interventions: Drug: Fulvestrant;   Drug: GDC-0032;   Drug: Letrozole
9 Active, not recruiting Helical Irradiation of Total Skin (HITS) for Cutaneous Lymphoma
Condition: Cutaneous T-cell Lymphoma
Intervention: Radiation: HITS
10 Terminated Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy
Condition: Breast Cancer
Interventions: Procedure: Breast MRI;   Procedure: Mammogram
11 Suspended Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Dose-Adjusted-Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (DA-TEDDI-R) in Primary CNS Lymphoma
Condition: Primary Central Nervious System Lymphoma
Interventions: Drug: TEDDI;   Biological: Rituximab;   Drug: Cytarabine;   Drug: TEDD;   Drug: Ibrutinib
12 Enrolling by invitation Helical Irradiation of Total Skin (HITS) for T Cell Lymphoma
Condition: T-cell Lymphoma
Intervention:
13 Terminated CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma
Condition: T-cell Non-Hodgkin Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Etoposide;   Drug: Prednisone;   Drug: Filgrastim;   Drug: Plerixafor;   Procedure: Stem Cell Collection;   Drug: Palifermin;   Drug: Gemcitabine;   Drug: Busulfan;   Drug: Melphalan;   Procedure: Stem Cell Transplant
14 Completed Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1
Condition: Human T-Lymphoma Virus Type I
Intervention:
15 Completed Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: Rituxan;   Drug: 1018 ISS
16 Completed A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies
Conditions: Lymphoma, Mantle-cell;   Leukemia, Lymphocytic, Chronic, B-Cell;   Leukemia, Hairy Cell;   Waldenstrom Macroglobulinemia;   Multiple Myeloma
Intervention: Drug: ON01910 Na
17 Recruiting A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
Condition: Hepatosplenic T-Cell Lymphoma
Intervention: Biological: Collection of samples
18 Recruiting Vinblastine and Temsirolimus in Pediatric Patients With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours
Conditions: Recurrent Lymphoma;   Refractory Lymphoma;   Solid Tumours;   Central Nervous System
Interventions: Drug: Vinblastine;   Drug: Temsirolimus
19 Active, not recruiting Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant
Conditions: Leukemia;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma;   Myelodysplastic Syndrome
Intervention: Other: Questionnaires, Laboratory tests, Abdominal MRI
20 Recruiting A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Previously Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Conditions: CLL (Chronic Lymphocytic Leukemia);   SLL (Small Lymphocytic Lymphoma)
Interventions: Drug: Ibrutinib;   Drug: Fludarabine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.